Central nervous system abnormalities in chromosome deletion at 11q23. 1994

J Ono, and K Harada, and T Hasegawa, and K Sakurai, and R Kodaka, and Y Tanabe, and J Tanaka, and T Igarashi, and T Nagai, and S Okada
Department of Pediatrics, Faculty of Medicine, Osaka University, Japan.

Two Japanese pediatric patients with terminal deletion of the long arm of chromosome 11 are described. Both had the morphological abnormalities of the 11q deletion syndrome, such as prominent epicanthal folds, broad flat nasal bridge with short, upturned nose, short philtrum with carp-shaped mouth, cardiac anomalies and nonprogressive moderate psychomotor developmental delay. Patient 1 is the first case to be reported with 11q deletion with serial magnetic resonance (MR) examinations of cerebral white matter. The initial MR imaging studies demonstrated multiple areas of T1 and T2 prolongation in the cerebral white matter in both patients at the ages of 2 5/12 and 2 1/12 years, respectively. A second MR imaging, performed 1 year after the first in Patient 1, demonstrated slight improvement of the lesions. Neither patient showed clinical deterioration. These results suggest that the lesions were caused by delayed myelination, rather than by demyelination. It is suggested that an unknown factor which is important for myelination is located on the long arm of chromosome 11: perhaps the neural cell adhesion molecule (NCAM).

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D009186 Myelin Sheath The lipid-rich sheath surrounding AXONS in both the CENTRAL NERVOUS SYSTEMS and PERIPHERAL NERVOUS SYSTEM. The myelin sheath is an electrical insulator and allows faster and more energetically efficient conduction of impulses. The sheath is formed by the cell membranes of glial cells (SCHWANN CELLS in the peripheral and OLIGODENDROGLIA in the central nervous system). Deterioration of the sheath in DEMYELINATING DISEASES is a serious clinical problem. Myelin,Myelin Sheaths,Sheath, Myelin,Sheaths, Myelin
D011596 Psychomotor Disorders Abnormalities of motor function that are associated with organic and non-organic cognitive disorders. Psychomotor Impairment,Developmental Psychomotor Disorders,Psychomotor Disorders, Developmental,Developmental Psychomotor Disorder,Impairment, Psychomotor,Impairments, Psychomotor,Psychomotor Disorder, Developmental,Psychomotor Impairments
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002658 Developmental Disabilities Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed) Child Development Deviations,Child Development Disorders,Child Development Disorders, Specific,Developmental Delay Disorders,Disabilities, Developmental,Development Disorders, Child,Child Development Deviation,Child Development Disorder,Development Deviation, Child,Development Deviations, Child,Development Disorder, Child,Developmental Delay Disorder,Developmental Disability,Deviation, Child Development,Disability, Developmental
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D002880 Chromosomes, Human, Pair 11 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 11

Related Publications

J Ono, and K Harada, and T Hasegawa, and K Sakurai, and R Kodaka, and Y Tanabe, and J Tanaka, and T Igarashi, and T Nagai, and S Okada
November 1995, Clinical genetics,
J Ono, and K Harada, and T Hasegawa, and K Sakurai, and R Kodaka, and Y Tanabe, and J Tanaka, and T Igarashi, and T Nagai, and S Okada
October 1998, The Journal of the American Osteopathic Association,
J Ono, and K Harada, and T Hasegawa, and K Sakurai, and R Kodaka, and Y Tanabe, and J Tanaka, and T Igarashi, and T Nagai, and S Okada
September 2000, British journal of cancer,
J Ono, and K Harada, and T Hasegawa, and K Sakurai, and R Kodaka, and Y Tanabe, and J Tanaka, and T Igarashi, and T Nagai, and S Okada
May 1992, Cancer genetics and cytogenetics,
J Ono, and K Harada, and T Hasegawa, and K Sakurai, and R Kodaka, and Y Tanabe, and J Tanaka, and T Igarashi, and T Nagai, and S Okada
May 1996, Leukemia & lymphoma,
J Ono, and K Harada, and T Hasegawa, and K Sakurai, and R Kodaka, and Y Tanabe, and J Tanaka, and T Igarashi, and T Nagai, and S Okada
June 1994, Leukemia & lymphoma,
J Ono, and K Harada, and T Hasegawa, and K Sakurai, and R Kodaka, and Y Tanabe, and J Tanaka, and T Igarashi, and T Nagai, and S Okada
June 1987, Human genetics,
J Ono, and K Harada, and T Hasegawa, and K Sakurai, and R Kodaka, and Y Tanabe, and J Tanaka, and T Igarashi, and T Nagai, and S Okada
January 1996, Cancer surveys,
J Ono, and K Harada, and T Hasegawa, and K Sakurai, and R Kodaka, and Y Tanabe, and J Tanaka, and T Igarashi, and T Nagai, and S Okada
January 1990, Radiologic clinics of North America,
J Ono, and K Harada, and T Hasegawa, and K Sakurai, and R Kodaka, and Y Tanabe, and J Tanaka, and T Igarashi, and T Nagai, and S Okada
October 2003, Expert opinion on pharmacotherapy,
Copied contents to your clipboard!